(Q24201116)

1

0 references

Ming Liu

2

0 references

Carl Counsell

3

0 references

Sen Lin

5

0 references

Xiaoling Zhao

Cochrane Database of Systematic Reviews

6

0 references

publication date

1 September 1996

0 references

published in

0 references

cites work

Ancrod for the treatment of acute ischemic brain infarction. The Ancrod Stroke Study Investigators

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000091.PUB2

Intravenous ancrod for acute ischaemic stroke in the European Stroke Treatment with Ancrod Trial: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000091.PUB2

Use of ancrod in acute or progressing ischemic cerebral infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000091.PUB2

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000091.PUB2

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000091.PUB2

Hospital management of acute ischemic stroke in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000091.PUB2

Blood pressure, stroke, and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000091.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000091.PUB2

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000091.PUB2

Thrombolysis for acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000091.PUB2

Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000091.PUB2

A systematic review of randomized evidence for fibrinogen-depleting agents in acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000091.PUB2

Fibrinogen depleting agents for acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000091.PUB2

Controlled Trial of Ancrod in Ischemic Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000091.PUB2

7 January 2021

Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000091.PUB2

7 January 2021

Thrombolysis for acute ischaemic stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000091.PUB2

7 January 2021

Carotid endarterectomy for symptomatic carotid stenosis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000091.PUB2

7 January 2021

High-dose atorvastatin after stroke or transient ischemic attack

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000091.PUB2

7 January 2021

Ancrod causes rapid thrombolysis in patients with acute stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000091.PUB2

7 January 2021

Ancrod in Acute Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000091.PUB2

7 January 2021